Our grant for Training in Cancer Biology has supported predoctoral training in the McArdle Laboratory for Cancer Research, and more recently, the University of Wisconsin Carbone Cancer Center (UWCCC), for 35 years, and is the educational core for cancer research at the University of Wisconsin-Madison. This competitive renewal seeks to continue our mission of providing the best training environment for the next generation of cancer researchers. This is a broad-based training program in experimental cancer research that is implemented by 38 UW faculty members with research programs focused on both basic and translational cancer research. Our trainers are highly committed to providing substantive training and mentoring for our trainees and they have a record of success. All trainers in the program are funded with peer-reviewed grants, supported by the NIH, DOD, and/or the ACS. They are engaged in multiple intra-programmatic collaborations which support collaborative grants and joint publications. Our grant currently supports 15 predoctoral trainees and we are requesting continued support for the same number of slots. Trainees represent students from a variety of graduate programs at UW-Madison, such as Cancer Biology, Cellular and Molecular Biology, and Molecular and Cellular Pharmacology. Students are eligible for a position on this grant upon passing their qualifying exam and achieving dissertator status. Importantly, they must demonstrate a clear commitment to cancer research. This training grant can boast a number of accomplishments during the last 5 years, including well-funded and interactive trainers, a productive publication record of trainees, and successful employment of trainees in cancer-research related activities. We have greatly increased the diversity of our trainee cohort and we will continue to prioritize recruitment efforts of students from traditionall under-represented groups. The program will be led by Dr. Bill Sugden who has been PI of this grant since 1987. Drs. Alarid and Loeb have been working with Dr. Sugden for the past two years and will continue to do so as Assistant Directors. Both investigators have a clear and demonstrated commitment to predoctoral training of cancer researchers. It is anticipated that they will evolve to become the co-Directors of this grant over its next funding period. This grant has supported the training of more than 450 scientists in cancer biology, initiating their careers in academia and industry to carry out robust cancer research throughout America. We seek to continue this excellent training of young scientists with this grant, which is the only training grnt on our campus dedicated to the predoctoral training of cancer researchers.

Public Health Relevance

This grant, entitled Training in Cancer Biology, has supported the training of cancer researchers at the University of Wisconsin-Madison for 35 years. The goal of this grant is to limit cancer maximally as a disease by educating the next generation of cancer researchers to be as committed and competent as is humanly possible. We shall both build on our past success and evolve this program to lead training in cancer research optimally into the future.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Perkins, Susan N
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Shea, Michael P; O'Leary, Kathleen A; Fakhraldeen, Saja A et al. (2018) Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER?+ Mammary Carcinomas. Cancer Res 78:1672-1684
Helzer, Kyle T; Ozers, Mary Szatkowski; Meyer, Mark B et al. (2018) The Phosphorylated Estrogen Receptor Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2. Mol Cell Biol :
Jallow, Fatou; Brockman, Jennifer L; Helzer, Kyle T et al. (2018) 17?-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes. J Endocr Soc 2:293-309
Evans 3rd, Edward L; Becker, Jordan T; Fricke, Stephanie L et al. (2018) HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific. J Virol 92:
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
Huynh, Mailee; Pak, Chorom; Markovina, Stephanie et al. (2018) Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-?B activity and increases drug resistance in multiple myeloma. J Biol Chem 293:2452-2465
Guo, Feng; Wlodarchak, Nathan; Menden, Patrick et al. (2018) Purification of Target Proteins from Native Tissues: CCT Complex from Bovine Testes and PP2Ac from Porcine Brains. Methods Mol Biol 1788:73-88
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Damodaran, Shivashankar; Damaschke, Nathan; Gawdzik, Joseph et al. (2017) Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes. BMC Cancer 17:874

Showing the most recent 10 out of 333 publications